| Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial F Ratjen, C Hug, G Marigowda, S Tian, X Huang, S Stanojevic, CE Milla, ... The lancet Respiratory medicine 5 (7), 557-567, 2017 | 323 | 2017 |
| Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis MM Treggiari, G Retsch-Bogart, N Mayer-Hamblett, U Khan, M Kulich, ... Archives of pediatrics & adolescent medicine 165 (9), 847-856, 2011 | 241 | 2011 |
| Cerebral palsy: A complete guide for caregiving F Miller, SJ Bachrach JHU Press, 2017 | 216 | 2017 |
| Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial BM Assael, T Pressler, D Bilton, M Fayon, R Fischer, R Chiron, M LaRosa, ... Journal of Cystic fibrosis 12 (2), 130-140, 2013 | 158 | 2013 |
| Cultured human airway epithelial cells (Calu‐3): a model of human respiratory function, structure, and inflammatory responses Y Zhu, A Chidekel, TH Shaffer Critical care research and practice 2010 (1), 394578, 2010 | 156 | 2010 |
| Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study MM Treggiari, M Rosenfeld, N Mayer-Hamblett, G Retsch-Bogart, ... Contemporary clinical trials 30 (3), 256-268, 2009 | 139 | 2009 |
| Long term effects of denufosol tetrasodium in patients with cystic fibrosis F Ratjen, T Durham, T Navratil, A Schaberg, FJ Accurso, C Wainwright, ... Journal of Cystic Fibrosis 11 (6), 539-549, 2012 | 124 | 2012 |
| Risk factors for lung function decline in a large cohort of young cystic fibrosis patients J Cogen, J Emerson, DB Sanders, C Ren, MS Schechter, RL Gibson, ... Pediatric pulmonology 50 (8), 763-770, 2015 | 122 | 2015 |
| The effects of gas humidification with high‐flow nasal cannula on cultured human airway epithelial cells A Chidekel, Y Zhu, J Wang, JJ Mosko, E Rodriguez, TH Shaffer Pulmonary medicine 2012 (1), 380686, 2012 | 120 | 2012 |
| Rhinovirus infection associated with serious lower respiratory illness in patients with bronchopulmonary dysplasia AS Chidekel, CL Rosen, AR Bazzy The Pediatric infectious disease journal 16 (1), 43-47, 1997 | 108 | 1997 |
| Costello syndrome: Clinical phenotype, genotype, and management guidelines KW Gripp, LA Morse, M Axelrad, KC Chatfield, A Chidekel, W Dobyns, ... American Journal of Medical Genetics Part A 179 (9), 1725-1744, 2019 | 99 | 2019 |
| Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis N Mayer‐Hamblett, RA Kronmal, RL Gibson, M Rosenfeld, ... Pediatric pulmonology 47 (2), 125-134, 2012 | 93 | 2012 |
| Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort M Rosenfeld, J Emerson, S McNamara, K Joubran, G Retsch‐Bogart, ... Pediatric pulmonology 45 (9), 934-944, 2010 | 70 | 2010 |
| Comprehensive pediatric hospital medicine LB Zaoutis, VW Chiang Elsevier Health Sciences, 2007 | 62 | 2007 |
| Postoperative bilevel positive airway pressure ventilation after tonsillectomy and adenoidectomy in children—a preliminary report O Friedman, A Chidekel, ST Lawless, SP Cook International journal of pediatric otorhinolaryngology 51 (3), 177-180, 1999 | 59 | 1999 |
| Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy E Rodriguez, MB Bober, L Davey, A Zamora, AB Li Puma, A Chidekel, ... Pediatric pulmonology 47 (9), 917-922, 2012 | 44 | 2012 |
| Anoxia-induced neuronal injury: role of Na+ entry and Na+-dependent transport AS Chidekel, JE Friedman, GG Haddad Experimental neurology 146 (2), 403-413, 1997 | 42 | 1997 |
| Cystic fibrosis and calcium oxalate nephrolithiasis. AS Chidekel, TF Dolan Jr The Yale journal of biology and medicine 69 (4), 317, 1996 | 41 | 1996 |
| Antibacterial Activity of Apical Surface Fluid from the Human Airway Cell Line Calu-3: Pharmacologic Alteration by Corticosteroids and β2-Agonists Y Zhang, WW Reenstra, A Chidekel American Journal of Respiratory Cell and Molecular Biology 25 (2), 196-202, 2001 | 39 | 2001 |
| Hyperoxia-induced changes in human airway epithelial cells: the protective effect of perflubron PBR Babu, A Chidekel, TH Shaffer Pediatric Critical Care Medicine 6 (2), 188-194, 2005 | 36 | 2005 |
